市場調查報告書

胰島素製劑的全球市場分析:2020年

Insulin Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 924097
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
胰島素製劑的全球市場分析:2020年 Insulin Drugs Global Market Report 2020
出版日期: 2020年02月05日內容資訊: 英文
簡介

本報告提供全球胰島素製劑市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 胰島素製劑市場特徵

第3章 胰島素製劑市場規模與成長

  • 全球胰島素製劑市場成果
  • 全球胰島素製劑市場預測

第4章 胰島素製劑市場區隔

  • 全球胰島素製劑市場,市場區隔:各產品類型,成果與預測
  • 全球胰島素製劑市場,市場區隔:各用途,成果與預測

第5章 胰島素製劑市場的各地區、各國分析

  • 全球胰島素製劑市場,各地區,成果與預測
  • 全球胰島素製劑市場,各國,成果與預測

第6章 亞太地區的胰島素製劑市場

  • 亞太地區的胰島素製劑市場概要
  • 亞太地區的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第7章 中國的胰島素製劑市場

  • 中國的胰島素製劑市場概要
  • 中國的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第8章 印度的胰島素製劑市場

  • 印度的胰島素製劑市場概要
  • 印度的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第9章 日本的胰島素製劑市場

  • 日本的胰島素製劑市場概要
  • 日本胰島素製劑市場,市場區隔:各產品類型,成果與預測

第10章 澳洲的胰島素製劑市場

  • 澳洲的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第11章 印尼的胰島素製劑市場

  • 印尼的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第12章 韓國的胰島素製劑市場

  • 韓國的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第13章 西歐的胰島素製劑市場

  • 西歐的胰島素製劑市場概要
  • 西歐的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第14章 英國的胰島素製劑市場

  • 英國的胰島素製劑市場概要
  • 英國的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第15章 德國的胰島素製劑市場

  • 德國的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第16章 法國的胰島素製劑市場

  • 法國的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第17章 東歐的胰島素製劑市場

  • 東歐的胰島素製劑市場概要
  • 東歐的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第18章 俄羅斯的胰島素製劑市場

  • 俄羅斯的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第19章 北美的胰島素製劑市場

  • 北美的胰島素製劑市場概要
  • 北美的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第20章 美國的胰島素製劑市場

  • 美國胰島素製劑市場概要
  • 美國胰島素製劑市場,市場區隔:各產品類型,成果與預測

第21章 南美的胰島素製劑市場

  • 南美的胰島素製劑市場概要
  • 南美的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第22章 巴西的胰島素製劑市場

  • 巴西的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第23章 中東的胰島素製劑市場

  • 中東的胰島素製劑市場概要
  • 中東的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第24章 非洲的胰島素製劑市場

  • 非洲的胰島素製劑市場概要
  • 非洲的胰島素製劑市場,市場區隔:各產品類型,成果與預測

第25章 胰島素製劑市場競爭情形和企業簡介

  • 胰島素製劑市場競爭情形
  • 胰島素製劑市場企業簡介
    • Apidra
    • Eli Lilly
    • Humalog
    • Humulin
    • Insuman

第26章 胰島素製劑市場上主要合併和收購

第27章 胰島素製劑市場趨勢與策略

第28章 胰島素製劑市場未來預測與潛在分析

第29章 附錄

目錄

Insulin Drugs Market Global Report 2020 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global insulin drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the insulin drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Insulin Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider insulin drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The insulin drugs market section of the report gives context. It compares the insulin drugs market with other segments of the insulin drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, insulin drugs indicators comparison.

Scope

Markets Covered: 1) By Product Type: Basal or Long Acting Insulins; Bolus or Fast-Acting Insulins; Traditional Human Insulins; Combination Insulins; Biosimilar Insulins 2) By Application: Type II Diabetes; Type I Diabetes; Gestational Diabetes; Prediabetes

Companies Mentioned: Apidra; Eli Lilly; Humalog; Humulin; Insuman

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Insulin Drugs Market Characteristics

3. Insulin Drugs Market Size And Growth

  • 3.1. Global Insulin Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Insulin Drugs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Insulin Drugs Market Segmentation

  • 4.1. Global Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Basal or Long Acting Insulins
    • Bolus or Fast-Acting Insulins
    • Traditional Human Insulins
    • Combination Insulins
    • Biosimilar Insulins
  • 4.2. Global Insulin Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Type II Diabetes
    • Type I Diabetes
    • Gestational Diabetes
    • Prediabetes

5. Insulin Drugs Market Regional And Country Analysis

  • 5.1. Global Insulin Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Insulin Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Insulin Drugs Market

  • 6.1. Asia-Pacific Insulin Drugs Market Overview
  • 6.2. Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Insulin Drugs Market

  • 7.1. China Insulin Drugs Market Overview
  • 7.2. China Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Insulin Drugs Market

  • 8.1. India Insulin Drugs Market Overview
  • 8.2. India Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Insulin Drugs Market

  • 9.1. Japan Insulin Drugs Market Overview
  • 9.2. Japan Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Insulin Drugs Market

  • 10.1. Australia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Insulin Drugs Market

  • 11.1. Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Insulin Drugs Market

  • 12.1. South Korea Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Insulin Drugs Market

  • 13.1. Western Europe Insulin Drugs Market Overview
  • 13.2. Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Insulin Drugs Market

  • 14.1. UK Insulin Drugs Market Overview
  • 14.2. UK Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Insulin Drugs Market

  • 15.1. Germany Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Insulin Drugs Market

  • 16.3. France Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Insulin Drugs Market

  • 17.1. Eastern Europe Insulin Drugs Market Overview
  • 17.2. Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Insulin Drugs Market

  • 18.1. Russia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Insulin Drugs Market

  • 19.1. North America Insulin Drugs Market Overview
  • 19.2. North America Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Insulin Drugs Market

  • 20.1. USA Insulin Drugs Market Overview
  • 20.2. USA Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Insulin Drugs Market

  • 21.1. South America Insulin Drugs Market Overview
  • 21.2. South America Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Insulin Drugs Market

  • 22.1. Brazil Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Insulin Drugs Market

  • 23.1. Middle East Insulin Drugs Market Overview
  • 23.2. Middle East Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Insulin Drugs Market

  • 24.1. Africa Insulin Drugs Market Overview
  • 24.2. Africa Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Insulin Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Insulin Drugs Market Competitive Landscape
  • 25.2. Insulin Drugs Market Company Profiles
    • 25.2.1. Apidra
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Eli Lilly
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Humalog
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Humulin
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Insuman
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Insulin Drugs Market

27. Insulin Drugs Market Trends And Strategies

28. Insulin Drugs Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer